Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yamasa Corporation is a Japanese company that, while historically known for soy sauce production, has established a world-leading position in the life sciences sector through its Biochemicals Division. The company specializes in the manufacture of nucleic acid-related compounds, including nucleosides, nucleotides, and nucleotide sugars, which serve as critical raw materials for pharmaceuticals and diagnostic reagents. Yamasa is a key supplier of mRNA vaccine components, such as cap analogs and pseudouridine, and provides CDMO services for the synthesis of specialized nucleic acid derivatives. Their expertise in enzymatic synthesis and fermentation allows for the large-scale production of high-purity compounds used in antiviral and anticancer drug development. Additionally, the company produces diagnostic enzymes and reagents used in clinical testing and research applications globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yamasa Corporation.